Objectives: This study aims to translate the Evaluation of Ankylosing Spondylitis Quality of Life (EASi-QoL) into the Turkish language and test its validity and reliability. Patients and methods: A total of 100 AS patients (74 males; 26 females; mean age 38.2±9.9 years; range 21 to 63 years) were included. The mean disease duration was 115.9±91.6 months. EASi-QoL was translated from English into Turkish, and synthesis, back translation, revision, and pretest stages were performed. All patients were asked to complete the Turkish version of EASi-QoL. The internal consistency of EASi-QoL was determined with Cronbach's alpha coefficient, and test-retest reliability was assessed by calculating the intra-class correlation coefficient. Confirmatory and explanatory factor analyses were performed to assess structural validity. Construct validity was also investigated by comparing the results of EASi-QoL with the
BackgroundAnkylosing spondylitis (AS) specific quality of life scales have been widely criticized so a new AS-specific quality of life scale, (EASi-QoL), was developed.ObjectivesThe aim of the current study is to determine the validity and reliability of the modified Turkish version of the EASi-QoL.MethodsA total of 100 patients with AS were included in the study. The ESR and CRP levels were measured as laboratory tests. Pain severity, the global assessment of the patient and the physician were performed on VAS. Disease activity was determined by BASDAI and ASDAS. MASES was used to evaluate the enthesopathy. BASFI was filled by the patients in order to determine the physical function. Mobility of the patients was determined BASMI-11. The ASQoL, was used in order to evaluate the quality of life of the patients. The EASi-QoL contains questions about physical function, disease activity, emotional well being and social participation. After the usual translation process the Turkish version of the EASi-QoL -QoL was administered to each participant twice with an interval of 72 hours. The EASi-QoL was compared with ASQoL, BASFI, BASDAI, ASDAS, BASMI, MASES, VAS, pain severity, global assessments of the patient and the physician,ResultsThe mean age of the patients was 38.15±9.87 years and the mean disease duration was 115.9±91.59 months. Cronbach's alpha coefficient of the EASi-QoL was 0. 910 in the physical function 0.893 in the disease activity, 0.935 in the emotional well-being, and 0.930 in the social contribution categories (>0.7) indicating the high reliability of the scale. There was a strong positive correlation between four subcategories of the EASi-QoL (physical function, disease activity, emotional well-being and social contribution) and ASQoL, BASDAI, BASFI, and pain severity, patient global assessment (p<0.01). The relationship between EASi-QoL and BASMI and MASES revealed a weak correlation in the physical function and disease activity categories, and a moderate degree of correlation in the emotional well-being and social contribution categories (p<0.05). In the current study, we demonstrated a strong correlation between EASi-QoL and ASDAS-ESR and ASDAS-CRP scores (p<0.001).ConclusionsOur study demonstrated that the EASi-QoL, which evaluates four major components of quality of life in AS (i.e., physical function, disease activity, emotional well-being, and social contribution), was strongly correlated with ASQoL. The disease activity subcategory correlated strongly with BASDAI, and the physical function subcategory correlated well with BASFI. Therefore, we determined that the Turkish version of the EASi-QoL is a reliable and valid scale that can be used in clinical practice to evaluate the quality of life in detail in AS patientsReferencesPackham JC, Jordan KP, Haywood KL,Garratt AM, Healey EL. Evaluation of Ankylosing Spondylitis Quality of Life questionnaire: responsiveness of a new patient-reported outcome measure.Rheumatology (Oxford) 2012 Apr;51 (4):707-14.Haywood KL, Garratt AM, Jordan KP, Healey EL, Pa...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.